Background: This phase I study was conducted to determine maximal tolerated dose (MTD) and dose-limiting toxicities (DLT) in patients with advanced solid tumors treated with the polyamine analog N1, N14-diethylhomospermine (DEHSPM).

Methods: Patients were treated with DEHSPM administered as a subcutaneous (SC) injection daily for five consecutive days repeated every 4 weeks. Three dose levels were examined starting at 12.5 mg/m2/day, escalating to 37.5 mg/m2/day.

Results: A total of 15 patients were enrolled. Dose limiting toxicities (grade 3 or 4) included nausea, vomiting, constipation, ileus, elevations of aspartate aminotransferase (AST) and alkaline phosphatase, hyperbilirubinemia, and ventricular bigeminy.

Conclusion: DEHSPM given as a SC injection is overall well tolerated at lower doses, but significant toxicities were observed at the 37.5mg/m2/day dose level. MTD was established at 25 mg/m2/day but further investigation with this study drug is not recommended secondary to the potential for neurotoxicities and hepatic damage as a result of cumulative doses.

Download full-text PDF

Source
http://dx.doi.org/10.1023/B:DRUG.0000011789.79368.aeDOI Listing

Publication Analysis

Top Keywords

polyamine analog
8
patients advanced
8
advanced solid
8
solid tumors
8
phase trial
4
trial polyamine
4
analog n1n14-diethylhomospermine
4
n1n14-diethylhomospermine dehspm
4
patients
4
dehspm patients
4

Similar Publications

Pelvic Desmoplastic Small Round Cell Tumor on 18F-PSMA PET/CT.

Clin Nucl Med

February 2025

From the Department of Nuclear Medicine, the First Medical Centre, Chinese PLA General Hospital, Beijing, China.

Desmoplastic small round cell tumor (DSRCT) as a subtype of sarcoma is rare and aggressive. We present the case of a 23-year-old man with a histologically confirmed DSRCT who underwent 18F-PSMA PET/CT before prostate biopsy and surgical resection of the tumor. It is well known that PSMA PET has a high accuracy for detecting clinically significant prostate adenocarcinoma and is useful in guiding prostate biopsy.

View Article and Find Full Text PDF

Garlic ( L.) is a species of the onion family () widely used as a food and a folk medicine. The objective of this study was to determine the effects of AGE (aged garlic extract) on pro-inflammatory genes relevant to COVID-19.

View Article and Find Full Text PDF

Overcoming resistance to arginine deprivation therapy using GC7 in pleural mesothelioma.

iScience

January 2025

Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

Pleural mesothelioma is a highly chemotherapy-resistant cancer. Approximately 50% of mesotheliomas do not express argininosuccinate synthetase 1 (ASS1), the rate-limiting enzyme in arginine biosynthesis, making arginine depletion with pegylated arginine deiminase (ADI-PEG20) an attractive therapeutic strategy. We investigated whether combinatory treatment composed of ADI-PEG20 and polyamine inhibitors constitutes a promising novel therapeutic strategy to overcome ADI-PEG20 resistance in mesothelioma patients.

View Article and Find Full Text PDF

PET/CT targeting prostate-specific membrane antigen (PSMA) is commonly used in patients with prostate cancer. PSMA has been found in other solid tumours, including primary brain tumours. The aim of this study was to evaluate the usefulness of [Ga]Ga-PSMA-11 PET/CT for preoperative diagnosis and 2-year prognosis.

View Article and Find Full Text PDF

Synthesis and in vitro leishmanicidal activity of novel N-arylspermidine derivatives.

Bioorg Chem

January 2025

Universidad de Buenos Aires, CONICET, Cátedra de Química Orgánica II, Departamento de Ciencias Químicas, Facultad de Farmacia y Bioquímica, Junín 956, 1113 Buenos Aires, Argentina. Electronic address:

Article Synopsis
  • The study focuses on creating and testing new N-arylspermidine derivatives for their effectiveness against Leishmania infantum, a parasite causing a neglected tropical disease.
  • These compounds were synthesized through a unique method involving cyclic amidines, demonstrating good potential with eight out of ten showing effective ecological concentrations (EC) against the parasite's intracellular form.
  • Two derivatives, 3b and 3h, exhibited comparable efficacy to the existing treatment Miltefosine, indicating promising candidates for further development and optimization in treating Leishmania infections.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!